In the case of INSR splicing, DM1 is associated to the generation of the insulin signaling resistant isoform IR-A in the skeletal muscle cells thus reducing the metabolic effects of insulin on these cells [164, 170]. The gene discussed is INSR; the disease is myotonic dystrophy type 1.